MOH — authorised 5 June 1965
- Marketing authorisation holder: MEDA PHARMS
- Status: likely_approved
MOH authorised Avc on 5 June 1965
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 5 June 1965.
MEDA PHARMS holds the Israeli marketing authorisation.